Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

STERIS Yönetim

Yönetim kriter kontrolleri 3/4

STERIS' CEO'su Dan Carestio, Jul2021 tarihinde atandı, in görev süresi 3.25 yıldır. in toplam yıllık tazminatı $ 9.55M olup, şirket hissesi ve opsiyonları dahil olmak üzere 10.8% maaş ve 89.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.057% ine doğrudan sahiptir ve bu hisseler $ 13.66M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.7 yıl ve 7.7 yıldır.

Anahtar bilgiler

Dan Carestio

İcra Kurulu Başkanı

US$9.6m

Toplam tazminat

CEO maaş yüzdesi	10.8%
CEO görev süresi	3.3yrs
CEO sahipliği	0.06%
Yönetim ortalama görev süresi	4.7yrs
Yönetim Kurulu ortalama görev süresi	7.7yrs

Son yönetim güncellemeleri

Recent updates

Is STERIS (NYSE:STE) A Risky Investment?

Oct 01

Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued

Sep 16

Earnings Tell The Story For STERIS plc (NYSE:STE)

Sep 13

Steris: Q2 Numbers Solidify Buy Thesis

Aug 13

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 59% Above Its Share Price

Aug 08

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

Mar 29

STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Mar 07

Steris: Strong Healthcare Products Growth Coupled With Weak AST Business

Feb 17

STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

Feb 15

An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued

Dec 17

Should You Investigate STERIS plc (NYSE:STE) At US$203?

Nov 24

Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes

Nov 08

We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt

Nov 06

Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?

Sep 18

Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage

Sep 01

When Should You Buy STERIS plc (NYSE:STE)?

Aug 10

Steris: Continuing To Grow The Product Lineup

Jun 20

Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered

Feb 09

Steris declares $0.47 dividend

Feb 01

These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well

Feb 01

Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)

Dec 28

Steris declares $0.47 dividend

Nov 02

STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Nov 01

Steris: Non-GAAP Valuations Supportive Of Substantial Upside

Sep 04

STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47

Aug 18

STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47

Aug 04

Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M

Aug 02

Is STERIS (NYSE:STE) A Risky Investment?

Jul 19

Steris: Deleveraging Key Undercurrent, Valuation A Concern

Jun 12

CEO Tazminat Analizi

Dan Carestio'un ücretlendirmesi STERIS'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	US$561m
Mar 31 2024	US$10m	US$1m	US$551m
Dec 31 2023	n/a	n/a	US$1b
Sep 30 2023	n/a	n/a	US$1b
Jun 30 2023	n/a	n/a	US$576m
Mar 31 2023	US$8m	US$970k	US$557m
Dec 31 2022	n/a	n/a	-US$28m
Sep 30 2022	n/a	n/a	-US$8m
Jun 30 2022	n/a	n/a	US$377m
Mar 31 2022	US$6m	US$767k	US$285m
Dec 31 2021	n/a	n/a	US$279m
Sep 30 2021	n/a	n/a	US$250m
Jun 30 2021	n/a	n/a	US$286m
Mar 31 2021	US$3m	US$542k	US$397m
Dec 31 2020	n/a	n/a	US$433m
Sep 30 2020	n/a	n/a	US$424m
Jun 30 2020	n/a	n/a	US$413m
Mar 31 2020	US$2m	US$522k	US$408m
Dec 31 2019	n/a	n/a	US$393m
Sep 30 2019	n/a	n/a	US$336m
Jun 30 2019	n/a	n/a	US$319m
Mar 31 2019	US$2m	US$482k	US$304m
Dec 31 2018	n/a	n/a	US$269m
Sep 30 2018	n/a	n/a	US$316m
Jun 30 2018	n/a	n/a	US$303m
Mar 31 2018	US$1m	US$379k	US$291m

Tazminat ve Piyasa: Dan 'ın toplam tazminatı ($USD 9.55M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 13.04M ).

Tazminat ve Kazançlar: Dan şirketinin tazminatı %20'den fazla artarken, şirketin kazancı geçen yıl %20'den fazla düştü.

CEO

Dan Carestio (51 yo)

3.3yrs

Görev süresi

US$9,550,776

Tazminat

Mr. Daniel A. Carestio, also known as Dan, serves as the Chief Executive Officer & President at STERIS plc since July 29, 2021. He had been Senior Vice President and Chief Operating Officer at STERIS plc s...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Daniel Carestio	President	3.3yrs	US$9.55m	0.057% $ 13.0m
Michael Tokich	Senior VP & CFO	16.6yrs	US$3.24m	0.047% $ 10.7m
John Zangerle	Senior VP	11.3yrs	US$2.63m	0.034% $ 7.7m
Mary Fraser	SVP & Chief Human Resources Officer	4.3yrs	US$1.85m	0.011% $ 2.6m
Cary Majors	Senior VP & President of Healthcare	5.2yrs	US$2.15m	0.013% $ 3.0m
Karen Burton	VP & Chief Accounting Officer	7.8yrs	Veri yok	0.0044% $ 1.0m
Julie Winter	Vice President of Investor Relations & Corporate Communications	no data	Veri yok	Veri yok
Julia Madsen	Senior VP & GM of Life Sciences	4.3yrs	Veri yok	0.0095% $ 2.2m
Andrew Xilas	Senior VP & GM of Dental	3.3yrs	US$1.92m	0.0064% $ 1.5m
Kenneth Kohler	Senior VP & GM of AST	no data	Veri yok	0.0035% $ 804.2k
Renato Tamaro	VP & Corporate Treasurer	7.2yrs	Veri yok	0.0069% $ 1.6m
Walter Rosebrough	CEO Emeritus & Senior Advisor	3.3yrs	US$1.16m	Veri yok

4.7yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: STE 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.7 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Daniel Carestio	President	3.8yrs	US$9.55m	0.057% $ 13.0m
Richard Breeden	Independent Director	16.5yrs	US$353.94k	0.033% $ 7.5m
Mohsen Sohi	Independent Chairman of the Board	19.3yrs	US$503.73k	0.023% $ 5.2m
Jacqueline Kosecoff	Independent Director	21yrs	US$348.93k	0.027% $ 6.2m
Cynthia Feldmann	Independent Director	19.6yrs	US$349.84k	0.0095% $ 2.2m
Richard Steeves	Independent Director	8.9yrs	US$349.96k	0% $ 0
Paul Martin	Independent Director	3.4yrs	US$342.28k	Veri yok
Nirav Shah	Independent Director	6.4yrs	US$336.34k	0.00030% $ 68.3k
Christopher Holland	Independent Director	4.3yrs	US$342.34k	0.00059% $ 134.4k
Esther Alegria	Independent Director	1.4yrs	US$408.96k	Veri yok

7.7yrs

Ortalama Görev Süresi

65.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: STE 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.7 yıldır).

STERIS Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Senior VP & CFO notifies of intention to sell stock

STERIS plc, Annual General Meeting, Aug 01, 2024

Senior VP & President of Healthcare notifies of intention to sell stock

Insufficient new directors

Independent Director notifies of intention to sell stock

STERIS plc Appoints Dr. Esther Alegria to Serve on the Compliance and Technology Committee and the Nominating and Governance Committee of the Board

Recent updates

Is STERIS (NYSE:STE) A Risky Investment?

Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued

Earnings Tell The Story For STERIS plc (NYSE:STE)

Senior VP & CFO notifies of intention to sell stock

Steris: Q2 Numbers Solidify Buy Thesis

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 59% Above Its Share Price

First quarter 2025 earnings: EPS exceeds analyst expectations

STERIS plc Provides Earnings Guidance for the Year 2025

Fourth quarter dividend increased to US$0.57

STERIS plc Raises Quarterly Interim Dividend, Payable on September 20, 2024

STERIS plc to Report Q1, 2025 Results on Aug 06, 2024

When Should You Buy STERIS plc (NYSE:STE)?

STERIS plc, Annual General Meeting, Aug 01, 2024

Is STERIS (NYSE:STE) Using Too Much Debt?

Senior VP & President of Healthcare notifies of intention to sell stock

Upcoming dividend of US$0.52 per share

Insufficient new directors

Independent Director notifies of intention to sell stock

STERIS plc Provides Earnings Guidance for the Fiscal Year 2025

Full year 2024 earnings: EPS misses analyst expectations

Third quarter dividend of US$0.52 announced

STERIS plc Announces Quarterly Interim Dividend, Payable on June 26, 2024

STERIS plc to Report Q4, 2024 Results on May 08, 2024

Steris: Moving On, Losing Its Teeth

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Steris: Strong Healthcare Products Growth Coupled With Weak AST Business

STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

Upcoming dividend of US$0.52 per share at 0.9% yield

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

STERIS plc Revises Financial Guidance for the Fiscal Year 2024

Second quarter dividend of US$0.52 announced

STERIS plc Announces Quarterly Interim Dividend, Payable on March 22, 2024

Now 21% undervalued

STERIS plc to Report Q3, 2024 Results on Feb 07, 2024

Now 20% undervalued

An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued

Should You Investigate STERIS plc (NYSE:STE) At US$203?

Upcoming dividend of US$0.52 per share at 1.0% yield

STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024

STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes

We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt

STERIS plc Announces Quarterly Interim Dividend, Payable on December 21, 2023

STERIS plc to Report Q2, 2024 Results on Nov 07, 2023

Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?

Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage

Upcoming dividend of US$0.52 per share at 0.9% yield

When Should You Buy STERIS plc (NYSE:STE)?

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

STERIS plc Appoints Dr. Esther Alegria to Serve on the Compliance and Technology Committee and the Nominating and Governance Committee of the Board

STERIS plc to Report Q1, 2024 Results on Aug 01, 2023

Steris: Continuing To Grow The Product Lineup

STERIS plc, Annual General Meeting, Jul 27, 2023

Upcoming dividend of US$0.47 per share at 0.9% yield

Independent Director recently sold US$578k worth of stock

Independent Director exercised options and sold US$785k worth of stock

STERIS plc Provides Revenue Guidance for the Fiscal Year 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

STERIS plc (NYSE:STE) announces an Equity Buyback for $500 million worth of its shares.

Insider recently sold US$219k worth of stock

Independent Director exercised options to buy US$863k worth of stock.

Upcoming dividend of US$0.47 per share at 0.9% yield

Third quarter 2023 earnings: Revenues miss analyst expectations

Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered

STERIS plc Updates Financial Guidance for the Fiscal Year Ending March 31, 2023

STERIS plc Declares Quarterly Interim Dividend, Payable on March 23, 2023

Steris declares $0.47 dividend